Rockwell Medical (NASDAQ:RMTI) Upgraded by StockNews.com to Buy Rating

StockNews.com upgraded shares of Rockwell Medical (NASDAQ:RMTI) from a hold rating to a buy rating in a research report report published on Wednesday.

Separately, HC Wainwright restated a “buy” rating and issued a $9.00 price objective on shares of Rockwell Medical in a research report on Wednesday, September 11th.

Rockwell Medical Stock Down 7.1 %

RMTI opened at $2.63 on Wednesday. The business’s fifty day moving average is $3.72 and its two-hundred day moving average is $2.60. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.60 and a current ratio of 2.00. The company has a market cap of $81.61 million, a price-to-earnings ratio of -52.60 and a beta of 1.50. Rockwell Medical has a one year low of $1.16 and a one year high of $5.15.

Rockwell Medical (NASDAQ:RMTI) last posted its earnings results on Tuesday, November 12th. The company reported $0.05 EPS for the quarter, topping analysts’ consensus estimates of $0.01 by $0.04. The company had revenue of $28.32 million for the quarter, compared to the consensus estimate of $25.99 million. Rockwell Medical had a positive return on equity of 9.27% and a negative net margin of 1.25%. Analysts anticipate that Rockwell Medical will post -0.03 EPS for the current fiscal year.

Hedge Funds Weigh In On Rockwell Medical

Several large investors have recently added to or reduced their stakes in RMTI. Armistice Capital LLC lifted its position in Rockwell Medical by 22.5% during the second quarter. Armistice Capital LLC now owns 3,221,640 shares of the company’s stock worth $5,670,000 after buying an additional 592,000 shares during the period. Renaissance Technologies LLC lifted its position in Rockwell Medical by 877.1% during the second quarter. Renaissance Technologies LLC now owns 102,700 shares of the company’s stock worth $181,000 after buying an additional 92,189 shares during the period. Corsair Capital Management L.P. purchased a new position in Rockwell Medical during the third quarter worth about $298,000. Vanguard Group Inc. lifted its position in Rockwell Medical by 4.0% during the first quarter. Vanguard Group Inc. now owns 1,118,277 shares of the company’s stock worth $1,856,000 after buying an additional 43,302 shares during the period. Finally, Beacon Financial Advisory LLC acquired a new stake in Rockwell Medical during the third quarter worth about $98,000. 23.31% of the stock is currently owned by hedge funds and other institutional investors.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.